Interacting Drugs |
Acebutolol vs Lidocaine (Systemic) |
Security Level |
|
Mechanism |
Lidocaine (Systemic): Beta-Blockers may decrease the metabolism of Lidocaine (Systemic). |
Management |
Monitor therapy |
Acebutolol vs Lidocaine (Systemic)
Post Review about Acebutolol vs Lidocaine (Systemic) Click here to cancel reply.
Other Interactions of Acebutolol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.